Why choosing Boehringer Ingelheim?
Boehringer Ingelheim has a strategic long-term oriented biopharmaceutical CMO business. Constant investments in our production plants guarantee state-of-the-art facilities. Highly experienced and customer-focused employees make sure that your project is in safe hands.
One-stop-shop concept offering
- Genetic engineering
- Cell line development
- Up- and downstream processing
- Formulation & pharmaceutical process development
- Fill & finish (including innovative application devices)
- Quality control & assurance
- Worldwide registration
- Option of out-licensing and marketing of your product
Your benefits at a glance
- Small and large scale production in multi-product plants approved by the European, US, Canadian authorities
- Working with an established privately owned and globally operating company
- Reliable partner for regulatory agencies, guarantee smooth registration proceedings
- Regularly audits by customers secure compliance with the latest standards and result in highest performance and good success rates
- Broad expertise in multifarious biopharmaceutical customer projects
- Contractual competence, which allows smooth and quick handling of all necessary agreements
- Experience in shipment of cell lines, frozen and liquid bulk material and drug product
- Vast knowledge in technology transfer and process adaptation
- Reliable financial standing which is important for a long-term arrangement
- Advantage from low costs of goods due to our balanced production programme
- Portfolio and capacity enlargement
- Flexibility in project uptake supported by a global network of production partners
- Accelerated entry to the market
